Calmark is a MedTech company developing and selling a point-of-care (POC) platform for diagnostics of medical conditions in newborns. The platform consists of a portable instrument and test cassettes for various biomarkers. The first test, Neo-Bilirubin, is currently being launched. Calmark aims to become the global leader in POC diagnostics for newborns and, in the long term, to offer all relevant tests for the first period of life.
